Sam Hooshmand
Neurology · Milwaukee, WINPI 1417310665
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $139,254 of the $229,256 with a category attached, or 60.7%. 12 manufacturers reported payments, led by TG Therapeutics, Inc. at 39.0% of the total. 2025 is the largest year on record at $131,552, more than ten times the $2,380 reported in 2020. Among neurology clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 236 payments — averaging $971.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TG Therapeutics, Inc.$89K
- EMD Serono, Inc.$86K
- Genentech USA, Inc.$31K
- Sanofi$13K
- Amgen$8K
- Novartis$1K
- plus $812 from 6 others
Across 14 payments — averaging $39,557 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$538K
- EMD Serono, Inc.$16K
What the payments were for
- Consulting fees$54,79724%
- Speaking & faculty fees$139,25461%
- Travel & lodging$25,37111%
- Food & beverage$9,8254%
- Education$100%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TG Therapeutics, Inc. | 68 | $89,478 |
| EMD Serono, Inc. | 85 | $86,112 |
| Genentech USA, Inc. | 23 | $30,924 |
| Sanofi | 18 | $12,984 |
| Amgen(2 entities) | 19 | $7,633 |
| Novartis | 14 | $1,314 |
| AstraZeneca | 3 | $243 |
| Roche Products Limited | 2 | $211 |
| Banner Life Sciences, LLC | 1 | $125 |
| Bristol Myers Squibb | 1 | $95 |
| Sanofi-aventis U.S. LLC | 1 | $87 |
| Biogen | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$229,256 in reported general payments places this provider in the 95th percentile of 308 neurology providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 30 | $266,671 |
| NuedextaDextromethorphan Hbr/Quinidine | 16 | $27,014 |
| Dalfampridine ErDalfampridine | 82 | $7,954 |
| Gabapentin | 146 | $5,505 |
| Baclofen | 182 | $4,371 |
| Modafinil | 49 | $4,218 |
| Carbamazepine | 50 | $2,535 |
| AmantadineAmantadine Hcl | 25 | $2,495 |
| Teriflunomide | 45 | $2,194 |
| Sumatriptan Succinate | 19 | $1,655 |
| Levetiracetam | 18 | $1,093 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 24 | $891 |
| Topiramate | 25 | $826 |
| Tizanidine Hcl | 57 | $818 |
| Mirtazapine | 25 | $489 |
Paid to pharmacies, not to this prescriber.
Other neurology in Milwaukee
- Bhupendra KhatriMilwaukee$2.5M
- Ahmed ObeidatMilwaukee$1.9M
- Staley BrodMilwaukee$1M
- Fallon SchloemerMilwaukee$48K
- Thulasirman RavichandranMilwaukee$47K
- Julia CollinsMilwaukee$21K
- Ryan BrennanMilwaukee$20K
- Elise JohnsonMilwaukee$11K
- Janel SchneiderMilwaukee$9K
- Teresa LeeMilwaukee$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.